Try our Advanced Search for more refined results

Pa. Judge Urged To Make J&J CEO Testify In Risperdal Trial

By Matt Fair ( January 18, 2019, 6:49 PM EST) -- A Pennsylvania state judge is weighing whether the CEO of Johnson & Johnson should be forced to take the stand at an upcoming trial over claims that labeling for the antipsychotic medication Risperdal failed to adequately warn about the risk of abnormal breast growth in adolescent boys....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies